PL376638A1 - Estry kwasu karbaminowego o działaniu antycholinergicznym - Google Patents

Estry kwasu karbaminowego o działaniu antycholinergicznym

Info

Publication number
PL376638A1
PL376638A1 PL376638A PL37663803A PL376638A1 PL 376638 A1 PL376638 A1 PL 376638A1 PL 376638 A PL376638 A PL 376638A PL 37663803 A PL37663803 A PL 37663803A PL 376638 A1 PL376638 A1 PL 376638A1
Authority
PL
Poland
Prior art keywords
carbamic acid
acid esters
anticholinergic action
anticholinergic
action
Prior art date
Application number
PL376638A
Other languages
English (en)
Inventor
Matthias Grauert
Michael P. Pieper
Steffen Breitfelder
Matthias Hoffmann
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of PL376638A1 publication Critical patent/PL376638A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL376638A 2002-11-26 2003-11-19 Estry kwasu karbaminowego o działaniu antycholinergicznym PL376638A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (de) 2002-11-26 2002-11-26 Neue Carbaminsäureester mit anticholinerger Wirksamkeit

Publications (1)

Publication Number Publication Date
PL376638A1 true PL376638A1 (pl) 2006-01-09

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376638A PL376638A1 (pl) 2002-11-26 2003-11-19 Estry kwasu karbaminowego o działaniu antycholinergicznym

Country Status (20)

Country Link
EP (1) EP1567526B1 (pl)
JP (1) JP4754829B2 (pl)
KR (1) KR20050086821A (pl)
CN (1) CN1717408A (pl)
AT (1) ATE392424T1 (pl)
AU (1) AU2003289880A1 (pl)
BR (1) BR0316549A (pl)
CA (1) CA2507110C (pl)
DE (2) DE10255040A1 (pl)
EA (1) EA200500775A1 (pl)
EC (1) ECSP055803A (pl)
ES (1) ES2304538T3 (pl)
HR (1) HRP20050465A2 (pl)
MX (1) MXPA05005443A (pl)
NO (1) NO20053089D0 (pl)
PL (1) PL376638A1 (pl)
RS (1) RS20050384A (pl)
UA (1) UA81649C2 (pl)
WO (1) WO2004048373A1 (pl)
ZA (1) ZA200502946B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE435862T1 (de) 2003-05-28 2009-07-15 Theravance Inc Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2008505118A (ja) * 2004-06-30 2008-02-21 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
EP1827439A4 (en) * 2004-11-15 2009-11-18 Glaxo Group Ltd NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
WO2007007282A2 (en) * 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
JP2009519310A (ja) * 2005-12-16 2009-05-14 アージェンタ ディスカバリー リミテッド 環状アミン誘導体およびそれらの使用
BRPI0806972A2 (pt) 2007-02-09 2014-04-08 Astellas Pharma Inc Composto cíclico contendo ponte azo
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071144A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION
EP3710483A4 (en) 2017-11-16 2021-10-20 XL-protein GmbH PASYLATED VEGFR / PDGFR FUSION PROTEINS AND THEIR USE IN THERAPY
EP3720852A1 (en) 2017-12-04 2020-10-14 Friedrich-Alexander-Universität Erlangen-Nürnberg Fluorophenyl substituted muscarinic receptor ligands with selectivity for m3 over m2
KR20220001259A (ko) 2020-06-29 2022-01-05 (주)아모레퍼시픽 표면처리된 무기입자, 이의 제조방법, 이의 분산액 및 이를 포함하는 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (fr) * 1969-11-26 1971-05-26 Knoll Ag Nouveaux carbamates et leur procede de preparation
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
WO1995006635A1 (en) * 1993-09-02 1995-03-09 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
WO1995021820A1 (en) * 1994-02-10 1995-08-17 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
CA2249410C (en) * 1996-03-20 2007-06-12 Wake Forest University Sigma-2 receptors as biomarkers of tumor cell proliferation

Also Published As

Publication number Publication date
ZA200502946B (en) 2005-11-23
WO2004048373A1 (de) 2004-06-10
HRP20050465A2 (en) 2006-10-31
EA200500775A1 (ru) 2005-12-29
NO20053089L (no) 2005-06-23
CA2507110C (en) 2012-07-10
EP1567526B1 (de) 2008-04-16
MXPA05005443A (es) 2005-08-03
CA2507110A1 (en) 2004-06-10
DE10255040A1 (de) 2004-06-03
UA81649C2 (ru) 2008-01-25
NO20053089D0 (no) 2005-06-23
KR20050086821A (ko) 2005-08-30
EP1567526A1 (de) 2005-08-31
DE50309655D1 (de) 2008-05-29
ATE392424T1 (de) 2008-05-15
BR0316549A (pt) 2005-10-04
JP4754829B2 (ja) 2011-08-24
AU2003289880A1 (en) 2004-06-18
JP2006514010A (ja) 2006-04-27
CN1717408A (zh) 2006-01-04
ECSP055803A (es) 2005-08-11
ES2304538T3 (es) 2008-10-16
RS20050384A (sr) 2007-12-31

Similar Documents

Publication Publication Date Title
MXPA04006677A (es) Procedimiento para la preparacion de esteres de escopina.
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
ZA200604719B (en) DPP-IV inhibitors
EP2722387A3 (en) Definitive endoderm
DE50304569D1 (de) Xanthencarbonsäureester des tropenols und scopins als m3-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
MY140164A (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
NO20053089D0 (no) Carbamidsyreestere med anticolinergisk virkning.
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
WO2004035800A3 (en) Intermediate cefdinir salts
EP1598341A8 (en) DPP-IV inhibitors
MY141020A (en) Novel pparalpha and ppargamma agonists
CA2421990A1 (en) .beta.-thioamino acids
WO2006021559A3 (de) Verfahren zur herstellung von tiotropiumsalzen und silicium-derivate als zwischenprodukte
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
WO2002088125A3 (de) Triazolopyrimidine mit fungizider wirkung
MXPA02012112A (es) Composiciones que contienen policarbonato.
WO2004024681A3 (fr) NOUVEAUX COMPOSES COMPRENANT UN GROUPEMENT THIOCARBONYLSULFANYLE UTILES POUR LA SYNTHESE DE COMPOSES α-PERFLUOROALKYLAMINES PAR VOIE RADICALAIRE
WO2001010861A3 (de) Substituierte heterocyclyl-2h-chromene
WO2003014094A3 (de) Heterocyclylarylsulfonamide
WO2004052831A3 (de) Verfahren zur herstellung optisch aktiver dihydropyrone
AU2003236339A1 (en) Novel polyether compound containing acid group and unsaturated group, process for producing the same, and resin composition
MY117435A (en) Process for preparing aryl-iminomethyl-carbamino acid esters
DE60227386D1 (de) Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)